Category: Pharma
Geo-Competition, RWE, and the Global Policy Storm
Pharma Market Access in 2025: Geo-Competition, RWE, and the Global Policy Storm In 2025, pharma market access is no longer just about clinical evidence and pricing. It’s now a geopolitical chessboard—where real-world evidence (RWE), health technology assessment (HTA), and policy shifts like U.S. tariffs are shaping which medicines reach patients and how fast. Join us…
Will Real-World Evidence (RWE), Decide Your Drug’s Price in 2025?
Real-World Evidence (RWE) Will Decide Your Drug’s Price in 2025 Drug pricing in 2025 is no longer driven solely by clinical trial data. Health authorities and payers now demand proof that drugs perform well in everyday use. Real-World Evidence (RWE) has become the backbone of value-based pricing. Its ability to reflect how patients respond outside…
Why Global Health Agencies Are Demanding RWE in 2025
Why Global Health Agencies Are Demanding Real-World Evidence in 2025 And What It Means for Market Access In 2025, healthcare is no longer defined by clinical trial results alone. Across the globe, regulatory bodies and health technology assessment (HTA) agencies are making one thing crystal clear: Real-World Evidence (RWE) is now a non-negotiable requirement for…
How RWE is Revolutionizing HTA in 2025
How Real-World Evidence (RWE) is Revolutionizing Health Technology Assessments (HTAs) in 2025 In 2025, the convergence of Real-World Evidence (RWE) and Health Technology Assessments (HTAs) is not just a trend, it’s a transformative shift in how healthcare systems evaluate and adopt innovation. As the demand grows for faster, more personalized, and cost-effective healthcare, RWE is…
How Generative AI & Wearables Transforming RWE and Market Access
How Generative AI and Wearables Are Redefining Real-World Evidence (RWE) and Market Access in 2025 In 2025, the healthcare industry is undergoing a profound transformation, driven by the dynamic convergence of Generative AI and wearable technologies. These innovations are not just influencing how data is gathered they are fundamentally reshaping the way Real-World Evidence (RWE)…
The Future of Pharma
The Future of Pharma: How Real-World Evidence & AI Are Shaping Market Access in 2025 Why 2025 Is the Breakthrough Year for Real-World Evidence (RWE)? In 2025, AI-driven healthcare and real-world data (RWD) are transforming how treatments are evaluated, approved, and accessed across global markets. Traditional clinical trials are no longer enough. Pharma companies are…
The Future of Real-World Evidence (RWE) & Market Access in 2025
Are You Ready to Dominate the Future of Real-World Evidence (RWE) & Market Access in 2025? How will AI and Machine Learning reshape healthcare? Can Real-World Evidence (RWE) revolutionize drug approvals and market access? What strategies will define success in an era driven by value-based healthcare and real-world data analytics? As 2025 approaches, the pharmaceutical…
The Must-Attend Event of the Year 2025
Why the Global RWE & Market Access Summit 2025 is the Must-Attend Event of the Year What is the Global RWE & Market Access Summit? The Global RWE (Real-World Evidence) and Market Access Summit 2025, set to take place from October 15th-16th in Frankfurt, Germany, is a premier event uniting thought leaders, industry experts, and…
